Essentials of Cardiopulmonary Physical Therapy

Physical therapy interventions
Ventilation
Summary
Discussion
6. Restrictive lung dysfunction
Etiology
Pathogenesis
Clinical manifestation
Infectious causes
Interstitial lung disease
Specific interstitial lung diseases
Connective tissue causes of restrictive lung dysfunction
Immunologic causes
Environmental/occupational causes
Asbestosis
Radiologic causes
Neoplastic causes
Nonsmall cell lung cancer
Pleural diseases
Cardiovascular causes
Neuromuscular causes
Musculoskeletal causes
Pregnancy as cause
Nutritional and metabolic causes
Traumatic causes
Therapeutic causes
Pharmaceutical causes
Summary
7. Chronic obstructive pulmonary diseases
Overall etiology, pathology, and pathophysiology of chronic obstructive pulmonary disease
Lung function in obstructive lung diseases
Symptoms associated with obstructive lung diseases
Physical and psychologic impairments associated with obstructive lung diseases
Quantification of impairment in obstructive lung diseases
Disease-specific obstructive lung conditions
Pediatric obstructive lung conditions
8. Pulmonary vascular disease
Symptoms of pulmonary hypertension
Diagnosis of pulmonary hypertension
Classification of pulmonary hypertension
Pathophysiology of pulmonary hypertension
Medical management
From diagnosis and medical management to follow-up
Activity/exercise limitations for individuals with pulmonary hypertension
Role of exercise in pulmonary hypertension
Summary
9. Cardiopulmonary implications of specific diseases
Introduction
Obesity
Diabetes mellitus
Clinical implications for physical therapy
Chronic kidney disease and failure
Other specific diseases and disorders
Cardiopulmonary toxicity of cancer treatment
Summary

Section 3. Diagnostic Tests and Procedures
10. Cardiovascular diagnostic tests and procedures
Diagnostic test interpretation and probability of disease
Sensitivity/specificity of testing
Clinical laboratory studies
Other noninvasive diagnostic tests
Other imaging modalities
Exercise testing
Pharmacologic stress testing
Cardiac catheterization: coronary angiography and ventriculography
Digital subtraction angiography
Endocardial biopsy
Vascular diagnostic testing for aortic, peripheral, and carotid disease
Peripheral arterial disease and dysfunction and diagnosis
Carotid artery disease and diagnosis
Summary
11. Electrocardiography
Basic electrophysiologic principles
Heart rhythm: assessment of single-lead electrocardiogram
Heart blocks
Ventricular arrhythmias
Other findings on a 12-lead electrocardiogram
Summary
12. Pulmonary diagnostic tests and procedures
Introduction
Chest imaging
Pulmonary function testing
Blood gas analysis
Oximetry
Cytologic and hematologic tests
Discussion
Summary

Section 4. Surgical Interventions, Monitoring, and Support
13. Cardiovascular and thoracic interventions
Introduction
Cardiothoracic surgical procedures
Chest tube placement
Cardiac surgical options: off-pump, minimally invasive, robotic-assisted
Pacemaker implantation
Implantable cardioverter defibrillator
Additional cardiovascular interventions
Peripheral vascular interventions
Myocardial and angiogenic gene therapy
Summary
14. Thoracic organ transplantation heart and lung
Introduction
History
Evaluation
Preoperative rehabilitation
Alternative therapies to transplantation
Donor selection and matching criteria
Surgical techniques
Medications
Postoperative treatment
Lung transplantation
Future trends in transplantation care160
Summary
15. Monitoring, life support devices, and respiratory care in intensive care unit
Monitoring equipment in the intensive care unit
Capnography
Invasive monitoring
Temperature monitoring
Intracranial pressure monitoring
Life support equipment
Summary

Section 5. Pharmacology
16. Cardiovascular medications
Pharmacokinetics
Pharmacodynamics
General considerations of pharmacologic management
Cardiac drugs used in critical care
Cardiac pharmacology in the geriatric population
Cardiac pharmacology in the neonate and pediatric populations
Pharmacologic management of diabetes
Heart transplantation
Vascular pharmacology
Summary
17. Pulmonary medications
Introduction
Physiology
Bronchomotor tone
Rationale for bronchodilators
Bronchodilators
New drug development
New antifibrotic medications (for the treatment of idiopathic pulmonary fibrosis)
Pulmonary arterial hypertension medications
New medications for cystic fibrosis
Ancillary pulmonary medications
Reserve antimicrobials
Summary
Section 6. Cardiopulmonary Assessment and Intervention
18. Examination and assessment procedures
Introduction
Elements of patient management
Patient history
Medical chart review
Interview with the patient and the family
Systems review
Physical examination
Evaluation
Summary
19. Interventions for acute cardiopulmonary conditions
Airway clearance techniques
Breathing strategies, positioning, and facilitation
Breathing exercises
Special considerations for mechanically ventilated patients
Exercise
Exercise considerations for specific cardiovascular patient populations
Special considerations for mobilizing patients on mechanical circulatory support
Injury prevention and equipment provision
Patient education
Discharge planning
Summary
20. Interventions and prevention measures for individuals with cardiovascular disease, or risk of disease
Introduction
Primary prevention
Rehabilitation of patients with documented cardiovascular disease
Management and evaluation of patients during the acute phase
Postacute phase rehabilitation
Candidacy
Home-based cardiac rehabilitation
Rehabilitation/secondary prevention in the outpatient setting
Secondary prevention: management of risk factors
Administrative considerations
Summary
21. Pulmonary rehabilitation
Choosing goals and outcomes in pulmonary rehabilitation
Structure of the pulmonary rehabilitation program
Physical therapy management
Patient evaluation procedures
Treatment intervention
Physical conditioning
Summary
22. Pediatric cardiopulmonary physical therapy
Respiratory system development
Cardiac development
Congenital heart defects
Cardiac medical management
Pediatric respiratory conditions
Pulmonary medical management with extracorporeal membranous oxygenation
Pediatric conditions with secondary cardiopulmonary issues
Pediatric conditions with decreased activity levels and/or altered posture
Physical therapy examination
Physical therapy evaluation, diagnosis, and prognosis
Physical therapy intervention
Summary
23. Outcome measures: A guide for the evidence-based practice of cardiopulmonary physical therapy
Introduction
Outcomes defined
Importance of measuring outcomes
Selection of data to measure
Functional performance measures
Quality-of-life measures
Summary
24. The lymphatic system
Introduction
Anatomy and physiology
Pathophysiology
The role of the lymphatic system in the cardiovascular system and in cardiovascular disease
Medical management
Lipedema
Summary

Glossary
Index